Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $481.81 | 4 | 72.3% |
| Education | $184.20 | 2 | 27.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $231.98 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $210.03 | 2 | $0 (2019) |
| Incyte Corporation | $125.00 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $99.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $249.83 | 2 | Incyte Corporation ($125.00) |
| 2018 | $416.18 | 4 | AstraZeneca Pharmaceuticals LP ($231.98) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Hematology/Oncology | ||||||
| 02/25/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $124.83 | General |
| 11/28/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 11/27/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 10/19/2018 | Takeda Pharmaceuticals U.S.A., Inc. | VELCADE (Drug) | Education | In-kind items and services | $85.20 | General |
| Category: Oncology | ||||||
| 09/20/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $106.98 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 884 | 2,098 | $238,120 | $52,550 |
| 2022 | 9 | 154 | 202 | $34,307 | $7,750 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 217 | $100,107 | $20,048 | 20.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 32 | 52 | $23,699 | $5,395 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $26,913 | $5,233 | 19.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 54 | 93 | $21,006 | $4,597 | 21.9% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 13 | 204 | $15,523 | $3,922 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 22 | $7,140 | $1,391 | 19.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 55 | 132 | $4,271 | $1,366 | 32.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 73 | 159 | $3,711 | $1,210 | 32.6% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2023 | 13 | 15 | $3,360 | $895.95 | 26.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 78 | $4,234 | $862.51 | 20.4% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 15 | 38 | $1,548 | $643.15 | 41.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 15 | 27 | $2,703 | $618.70 | 22.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 23 | 36 | $1,742 | $592.56 | 34.0% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 19 | 65 | $1,782 | $592.36 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 43 | 69 | $882.00 | $579.60 | 65.7% |
| 87522 | Detection test by nucleic acid for hepatitis c virus, quantification | Office | 2023 | 13 | 13 | $1,659 | $545.74 | 32.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 31 | 37 | $1,364 | $494.32 | 36.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 21 | 38 | $2,014 | $461.94 | 22.9% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 16 | 28 | $1,952 | $452.26 | 23.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 27 | 28 | $1,265 | $413.84 | 32.7% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 16 | 73 | $6,245 | $373.01 | 6.0% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Office | 2023 | 12 | 15 | $570.00 | $328.35 | 57.6% |
| 83550 | Iron binding capacity | Office | 2023 | 29 | 35 | $882.00 | $299.95 | 34.0% |
| 83540 | Iron level | Office | 2023 | 30 | 36 | $656.00 | $228.24 | 34.8% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 30 | 34 | $585.00 | $201.28 | 34.4% |
About Dr. Sheetal Kumar, DO
Dr. Sheetal Kumar, DO is a Hematology & Oncology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1942682133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheetal Kumar, DO has received a total of $666.01 in payments from pharmaceutical and medical device companies, with $249.83 received in 2019. These payments were reported across 6 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($481.81).
As a Medicare-enrolled provider, Kumar has provided services to 1,038 Medicare beneficiaries, totaling 2,300 services with total Medicare billing of $60,300. Data is available for 2 years (2022–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Providence, RI
- Active Since 06/24/2015
- Last Updated 12/03/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942682133
Products in Payments
- IMFINZI (Drug) $231.98
- JAKAFI (Drug) $125.00
- IMBRUVICA (Drug) $99.00
- VELCADE (Drug) $85.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Providence
Ritesh Rathore, Md, MD
Hematology & Oncology — Payments: $324,296
Anthony Mega, Md, MD
Hematology & Oncology — Payments: $193,307
Dr. Adam Olszewski, M.d, M.D
Hematology & Oncology — Payments: $47,507
John Reagan, Md, MD
Hematology & Oncology — Payments: $35,520
Hina Khan, M.d, M.D
Hematology & Oncology — Payments: $19,225
Dr. Joseph Dibenedetto, Md, MD
Hematology & Oncology — Payments: $6,205